2024 High Conviction - Giant Biogene - Growth Rate Keeps Moving Higher
Giant Biogene was listed in Hong Kong IPO in 2022. It has done well since and is now trading 45% above its IPO price, but its still cheap.
444 Views
Tencent Investee Selldown - The US$120bn Global Overhang
There have been multiple reports that Tencent (700 HK) plans to trim its investment portfolio over the remainder of the year. We look at Tencent's...
538 Views
Kuaishou - Q2 2021 Preview Through a Forensic Lens
Kuaishou's revenue and profitability prospects remain uncertain, particularly in the wake of stricter regulations and overseas expansion hurdles....
340 Views
Zhihu (ZH US/2390 HK): Negative EV Play Launches a Share Buyback at HK$9.11/US$3.50
Zhihu aims to return 19% of cash not subject to PRC government control, below Douyu’s comparable return of 34%. Expect more cash-rich US-China...
425 Views
Smartkarma Corporate Webinar | Kuaishou: A Leading Short Video Platform & Content Community in China
For our next Corporate Webinar, we are glad to welcome Kuaishou Technology’s Head of Capital Market and Investor Relations, Matthew Huaxia Zhao.
2.5k Views